{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:12:45Z","timestamp":1792811565010,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11239-019-01866-1","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T18:44:18Z","timestamp":1556649858000},"page":"528-531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy"],"prefix":"10.1007","volume":"48","author":[{"given":"Leonardo","family":"Di Gennaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimondo","family":"De Cristofaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"De Candia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"1866_CR1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893\u20132962","journal-title":"Eur Heart J"},{"issue":"8","key":"1866_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/europace\/euy054","volume":"20","author":"J Steffel","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Georg Haeusler K, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidb\u00fcchel H, ESC Scientific Document Group (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. Europace 20(8):1231\u20131242","journal-title":"Europace"},{"issue":"9","key":"1866_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s40264-016-0443-8","volume":"39","author":"JL Fitzgerald","year":"2016","unstructured":"Fitzgerald JL, Howes LG (2016) Drug interactions of direct-oral anticoagulants. Drug Saf 39(9):841\u2013845","journal-title":"Drug Saf"},{"key":"1866_CR4","unstructured":"Lixiana: summary of products characteristics. \n                    https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/lixiana#product-information-section\n                    \n                  . Accessed 8 Oct 2018"},{"key":"1866_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-019-01838-5","author":"A Amin","year":"2019","unstructured":"Amin A, Keshishian A, Dina O, Dhamane A, Nadkarni A, Carda E, Russ C, Rosenblatt L, Mardekian J, Yuce H, Baker CL (2019) Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population. J Thromb Thrombolysis. \n                    https:\/\/doi.org\/10.1007\/s11239-019-01838-5","journal-title":"J Thromb Thrombolysis"},{"key":"1866_CR6","unstructured":"U.S. Food and Drug Administration (2018) Drug development and drug interactions: table of substrates, inhibitors and inducers. \n                    https:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/DrugInteractionsLabeling\/ucm093664.htm\n                    \n                  . Accessed 8 Feb 2018"},{"key":"1866_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.clpt.2004.04.011","volume":"76","author":"T Giessmann","year":"2004","unstructured":"Giessmann T, May K, Modess C, Wegner D, Hecker U, Zschiesche M et al (2004) Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans. Clin Pharmacol Ther 76:192\u2013200","journal-title":"Clin Pharmacol Ther"},{"issue":"89","key":"1866_CR8","first-page":"1","volume":"1","author":"H Bortz","year":"2018","unstructured":"Bortz H, Corallo CE, Tran H (2018) Increasing understanding regarding the risk of concomitant use of carbamazepine and direct oral anticoagulants. J Pharm Pract 1(89):1\u20133","journal-title":"J Pharm Pract"},{"key":"1866_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pjnns.2017.01.010","volume":"51","author":"C St\u00f6llberger","year":"2017","unstructured":"St\u00f6llberger C, Finsterer J (2017) Recurrent venous thrombosis under rivaroxaban and carbamazepine for sumptomatic epilepsy. Neurol Neurochir Pol 51:194\u2013196","journal-title":"Neurol Neurochir Pol"},{"key":"1866_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-018-01804-7","author":"A Perlman","year":"2019","unstructured":"Perlman A, Hochberg-Klein S, Choshen Cohen L, Dagan G, Hirsh-Raccah B, Horwitz E, Aldouby-Bier G, Negev T, Matok I, Azoulay L, Kalish Y, Muszkat M (2019) Management strategies of the interaction between direct oral anticoagulant and drug-metabolizing enzyme inducers. J Thromb Thrombolysis. \n                    https:\/\/doi.org\/10.1007\/s11239-018-01804-7","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"1866_CR11","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1124\/dmd.112.046888","volume":"40","author":"MS Bathala","year":"2012","unstructured":"Bathala MS, Masumoto H, Oguma T, He L, Lowrie C, Mendell J (2012) Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans. Drug Metab Dispos 40(12):2250\u20132255","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"1866_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s11239-015-1185-7","volume":"39","author":"A Cuker","year":"2015","unstructured":"Cuker A, Husseinzadeh H (2015) Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review. J Thromb Thrombolysis 39(3):288\u2013294","journal-title":"J Thromb Thrombolysis"},{"issue":"9","key":"1866_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fneur.2018.01067","volume":"7","author":"A Galgani","year":"2018","unstructured":"Galgani A, Palleria C, Iannone LF, De Sarro G, Giorgi FS, Maschio M, Russo E (2018) Pharmacokinetic interactions of clinical interest between direct oral anticoagulants and antiepileptic drugs. Front Neurol 7(9):1067","journal-title":"Front Neurol"},{"key":"1866_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.eplepsyres.2016.06.003","volume":"126","author":"C St\u00f6llberger","year":"2016","unstructured":"St\u00f6llberger C, Finsterer J (2016) Interactions between non-vitamin K oral anticoagulants and antiepileptic drugs. Epilepsy Res 126:98\u2013101","journal-title":"Epilepsy Res"},{"key":"1866_CR15","unstructured":"Guida alla Terapia Antitrombotica, XVI edizione 2017. Raccomandazioni della Federazione dei Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA)"},{"issue":"1","key":"1866_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1055\/s-0038-1675816","volume":"119","author":"R Caterina De","year":"2019","unstructured":"De Caterina R, Ageno W, Agnelli G, Chan NC, Diener HC, Hylek E, Raskob GE, Siegal DM, Verheugt FWA, Lip GYH, Weitz JI (2019) The non-vitamin K antagonist oral anticoagulants in heart disease: section V-special situations. Thromb Haemost 119(1):14\u201338","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01866-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-019-01866-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01866-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T23:05:45Z","timestamp":1588115145000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-019-01866-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1007\/s11239-019-01866-1","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]},"assertion":[{"value":"30 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declared no conflicts of interest with respect to the authorship and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}